EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autophagy Modulation in Cancer Immunotherapy, Emerging Molecular Targets and Drug Selection Strategies

Maroua Jalouli, Abdel Halim Harrath iD, Mohammed Al-Zharani, Md Ataur Rahman iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27052183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Maroua Jalouli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia. Hauptthemen laut MEDLINE: Autophagy, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has revolutionized the treatment of cancer by harnessing the immune system to recognize and destroy malignant cells. However, a substantial proportion of patients exhibit primary or acquired resistance to these therapies, underscoring the urgent need to identify novel molecular targets to enhance therapeutic efficacy. Autophagy, an evolutionarily conserved cellular process of degradation and recycling, has emerged as a critical modulator of tumor immunity and the function of immune cells. In cancer cells, autophagy modulates antigen presentation, immunogenic cell death, metabolic reprogramming, and resistance to immune-mediated cell death. Concurrently, autophagy rigorously governs the viability, differentiation, and functional capacity of immune cells, including T cells, dendritic cells, macrophages, and natural killer (NK) cells. Dysfunctional autophagic flux in the tumor microenvironment can enhance immune evasion and limit the efficacy of immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines. In this review, we provide an in-depth analysis of emerging molecular targets involved in the regulation of autophagy relevant to cancer immunotherapy. This includes key signaling pathways such as PI3K/AKT/mTOR, AMPK, Beclin-1 complexes, ULK1, and lysosomal regulators. Additionally, we explore the rational integration of the pharmacological modulation of autophagy, including small molecules, natural compounds, and nanoparticle-based drug delivery systems, with immunotherapeutic approaches. We highlight the importance of rational drug selection and combination therapies to overcome resistance to immunotherapy and minimize toxicity. Understanding the context-dependent role of autophagy will be essential for the development of next-generation, precision-targeted cancer immunotherapies. Therefore, a comprehensive understanding of the context-specific functions of autophagy in tumor and immune cells is crucial for devising precision-targeted combination methods that overcome immunotherapy resistance and produce more sustainable cancer treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyNeoplasmsImmunotherapyHumansAnimalsTumor MicroenvironmentMolecular Targeted TherapySignal TransductionHost-Directed Therapy

Stichwörter der Autor:innen

autophagy modulationcancer immunotherapycombination therapydrug selection strategiesmolecular targetstumor microenvironment

Autor:innen und Institutionen

  • Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
  • Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

ORCID-Profile: Abdel Halim Harrath, Md Ataur Rahman

Förderung

  • Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University

Zitieren

APA

Jalouli, M., Harrath, A. H., Al-Zharani, M., & Rahman, M. A. (2026). Autophagy Modulation in Cancer Immunotherapy, Emerging Molecular Targets and Drug Selection Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052183

Vancouver

Jalouli M, Harrath AH, Al-Zharani M, Rahman MA. Autophagy Modulation in Cancer Immunotherapy, Emerging Molecular Targets and Drug Selection Strategies. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052183

BibTeX
@article{Jalouli2026,
  author = {Jalouli, Maroua and Harrath, Abdel Halim and Al-Zharani, Mohammed and Rahman, Md Ataur},
  title = {Autophagy Modulation in Cancer Immunotherapy, Emerging Molecular Targets and Drug Selection Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27052183}
}
Kostenlos starten →